Dr. Aincy’s expertise lies in electrophysiological measurements, as well as in vivo and in vitro experimentation. Before joining Cilcare, she worked on evaluating the molecular, cellular, and physiological mechanisms of drug candidates targeting neurodegenerative and psychiatric diseases. At Cilcare, Dr. Aincy brings strong technical expertise in cochlear histology, immunohistochemistry, and biological sampling.